Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|September 25, 2023
Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancerXiaoli Liu, Alexander ChiCancers|November 28, 2013
Treatment of brain metastasis from lung cancerAlexander Chi, Ritsuko KomakiFrontiers in Immunology|June 28, 2023
Mechanistic rationales for combining immunotherapy with radiotherapyAlexander Chi, Nam Phong NguyenFrontiers in Oncology|October 24, 2014
The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancerAlexander Chi, Nam P NguyenFrontiers in Oncology|August 20, 2014
4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CTAlexander Chi, Nam P NguyenCancers|July 9, 2022
Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung CancerAlexander Chi, Nam P NguyenBiomarker Research|November 21, 2013
EGFR inhibition in non-small cell lung cancer: current evidence and future directionsAlexander Chi, Scot Remick, William TseFrontiers in Oncology|July 11, 2014
The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastasesAlexander Chi, Nam Phong Nguyen, Ritsuko KomakiJAMA Network Open|November 21, 2019
Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body RadiotherapyAlexander Chi, Wei Fang, Yeping Sun, et al.Clinical Laboratory|February 7, 2017
Serum Amyloid P-component Level May be a Biomarker for Lung Toxicities and Overall Survival after Thoracic Radiotherapy for Non-small Cell Lung CancerJing Zhao, Alexander Chi, Rui Mao, et al.Pageof 6